Titulo:
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2
.
Guardado en:
1794-2470
2462-9448
18
2020-09-25
61
66
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_unicolmayor_nova_9_article_1814 |
|---|---|
| record_format |
ojs |
| spelling |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 Lozano Jiménez, Yenny Yolanda Sánchez Mora, Ruth Mélida Giraldo Quintero, Sara Emilia SARS-CoV-2 peptide therapeutic strategy vaccine SARS-CoV-2 péptidos estrategia terapéutica vacuna 18 35 Núm. 35 , Año 2020 : Especial Covid-19 Artículo de revista Journal article 2020-09-25 16:13:55 2020-09-25 16:13:55 2020-09-25 application/pdf Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD NOVA 1794-2470 2462-9448 https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1814 10.22490/24629448.4187 https://doi.org/10.22490/24629448.4187 https://creativecommons.org/licenses/by-nc-sa/4.0/ 61 66 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. World Health Organization. Coronavirus disease (COVID-2019) situation reports. Situation report—55. 2020 [ciitado el 17 de junio]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2 Vankadari N, Wilce JA. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect [Internet]. 2020 Jan 1;9(1):601–4. DOI: 10.1080/22221751.2020.1739565 Venkatagopalan P, Daskalova SM, Lopez LA, Dolezal KA, Hogue BG. Coronavirus envelope (E) protein remains at the site of assembly. Virology. 2015;478:75–85. Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–36. Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science (80). 2005; 309(5742):1864–8. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020. Dutta K. A novel peptide analogue of spike glycoprotein shows antiviral properties against SARS-CoV-2. 2020. DOI: 10.21203/rs.3.rs-32796/v1 Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30(4):343–55. Zhang L, Lin D, Sun X, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020;368(6489):409-412. doi:10.1126/science.abb3405 Pérez Escoda MT. Diseño y síntesis de péptidos para el diagnóstico de la infección por el virus de la hepatitis G (GBV-C/HGV). Universitat de Barcelona; 2007. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007;6(5):404–14. Pant S, Singh M, Ravichandiran V, Murty USN, Srivastava HK. Peptide-like and small-molecule inhibitors against Covid-19. J Biomol Struct Dyn. 2020;1–10. Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, et al. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach. Biomed Res Int. 2020. World Health Organization. Proyecto de panorama de las vacunas candidatas COVID-19 [Internet]. 2020 [citado el 17 de junio]. Disponible en: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines https://revistas.unicolmayor.edu.co/index.php/nova/article/download/1814/2687 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/redcol/resource_type/ARTREF info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
UNIVERSIDAD COLEGIO MAYOR DE CUNDINAMARCA |
| thumbnail |
https://nuevo.metarevistas.org/UNIVERSIDADCOLEGIOMAYORDECUNDINAMARCA/logo.png |
| country_str |
Colombia |
| collection |
NOVA |
| title |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 |
| spellingShingle |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 Lozano Jiménez, Yenny Yolanda Sánchez Mora, Ruth Mélida Giraldo Quintero, Sara Emilia SARS-CoV-2 peptide therapeutic strategy vaccine SARS-CoV-2 péptidos estrategia terapéutica vacuna |
| title_short |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 |
| title_full |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 |
| title_fullStr |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 |
| title_full_unstemmed |
Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2 |
| title_sort |
potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por sars-cov-2 |
| author |
Lozano Jiménez, Yenny Yolanda Sánchez Mora, Ruth Mélida Giraldo Quintero, Sara Emilia |
| author_facet |
Lozano Jiménez, Yenny Yolanda Sánchez Mora, Ruth Mélida Giraldo Quintero, Sara Emilia |
| topic |
SARS-CoV-2 peptide therapeutic strategy vaccine SARS-CoV-2 péptidos estrategia terapéutica vacuna |
| topic_facet |
SARS-CoV-2 peptide therapeutic strategy vaccine SARS-CoV-2 péptidos estrategia terapéutica vacuna |
| citationvolume |
18 |
| citationissue |
35 |
| citationedition |
Núm. 35 , Año 2020 : Especial Covid-19 |
| publisher |
Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD |
| ispartofjournal |
NOVA |
| source |
https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1814 |
| language |
|
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2020-09-25 |
| date_accessioned |
2020-09-25 16:13:55 |
| date_available |
2020-09-25 16:13:55 |
| url |
https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1814 |
| url_doi |
https://doi.org/10.22490/24629448.4187 |
| issn |
1794-2470 |
| eissn |
2462-9448 |
| doi |
10.22490/24629448.4187 |
| citationstartpage |
61 |
| citationendpage |
66 |
| url2_str_mv |
https://revistas.unicolmayor.edu.co/index.php/nova/article/download/1814/2687 |
| _version_ |
1811200269736738816 |